J Korean Thyroid Assoc.
2015 May;8(1):14-18. 10.11106/cet.2015.8.1.14.
Low Dose versus High Dose Radioiodine Therapy
- Affiliations
-
- 1Department of Nuclear Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea. won@dsmc.or.kr
- KMID: 2149616
- DOI: http://doi.org/10.11106/cet.2015.8.1.14
Abstract
- Since 1946, radioiodine (I-131) therapy has been one of the standard treatments for differentiated thyroid cancer (DTC). Recently the occurrence of thyroid cancer was markedly increasing and most of them were limited disease. Several reports said that there is no significant difference of outcome between low and high dose radioiodine therapy in patients with low to intermediate risk category of thyroid cancer. In this review, current effectiveness and toxicity of radioiodine ablation will be compared between low and high dose radioiodine in patient with low to intermediate risk DTC.
Keyword
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Radioiodine Therapy: Review of the Empiric Fixed Dose Approaches and Their Selective Applications
- Are Medical Personnel Safe from Radiation Exposure from Patient Receiving Radioiodine Ablation Therapy?
- Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults
- Methods and Clinical Efficacy of Dosimetry-Based Treatment in Radioiodine Therapy of Thyroid Cancer
- A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer
